Related Experiment Video
Updated: Apr 11, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy
Jenna Dean1, Sherwin Dela Cruz1, Puja K Mehta1
1Barbra Streisand Women's Heart Center, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, 127 South San Vicente Boulevard, A3600, Los Angeles, CA 90048, USA.
Insights
Coronary microvascular dysfunction is a key cause of myocardial ischaemia, especially in women who often lack obstructive coronary artery disease. Further research is needed to guide effective treatments for this condition.
Area of Science:
- Cardiology
- Vascular Medicine
- Women's Health
Background:
- Cardiovascular disease remains the leading global cause of mortality.
- Women with myocardial ischaemia symptoms frequently lack obstructive coronary artery disease (CAD), leading to misdiagnosis.
- Coronary microvascular dysfunction (CMD) is increasingly recognized as a cause of ischaemic heart disease.
Purpose of the Study:
- To review the prevalence, presentation, diagnosis, and treatment of coronary microvascular dysfunction.
- To highlight the specific challenges and considerations for ischaemic heart disease in women.
- To emphasize the importance of considering CMD in patients without obstructive CAD.
Main Methods:
- This is a review article, synthesizing existing literature.
- The review discusses diagnostic criteria and therapeutic approaches for CMD.
- Emphasis is placed on clinical presentation and epidemiological data.
Main Results:
- Coronary microvascular dysfunction is characterized by impaired coronary flow reserve due to microcirculatory abnormalities.
- It is associated with adverse cardiovascular outcomes and is often overlooked in women.
- Current treatments may include lifestyle changes and medications, but outcome data are limited.
Conclusions:
- Coronary microvascular dysfunction is a significant contributor to ischaemic heart disease, particularly in women.
- Accurate diagnosis and targeted therapies for CMD are crucial for improving cardiovascular prognosis.
- Further clinical trials are essential to establish evidence-based treatment guidelines for CMD.
Abstract:
Cardiovascular disease is the leading cause of death worldwide. In the presence of signs and symptoms of myocardial ischaemia, women are more likely than men to have no obstructive coronary artery disease (CAD). Women have a greater burden of symptoms than men, and are often falsely reassured despite the presence of ischaemic heart disease because of a lack of obstructive CAD. Coronary microvascular dysfunction should be considered as an aetiology for ischaemic heart disease with signs and symptoms of myocardial ischaemia, but no obstructive CAD. Coronary microvascular dysfunction is defined as impaired coronary flow reserve owing to functional and/or structural abnormalities of the microcirculation, and is associated with an adverse cardiovascular prognosis. Therapeutic lifestyle changes as well as antiatherosclerotic and antianginal medications might be beneficial, but clinical outcome trials are needed to guide treatment. In this Review, we discuss the prevalence, presentation, diagnosis, and treatment of coronary microvascular dysfunction, with a particular emphasis on ischaemic heart disease in women.
More Related Videos
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures

